With repeated relapse among patients and the disease becoming resistant to therapy, indolent and slow-growing non-Hodgkin lymphoma is now getting difficult to deal with. But a new drug made by Seattle-based Gilead Sciences Inc. appears to offer hope for fighting the disease, according to a study published online today in the iNew England Journal of Medicine/i in advance of its March 13 print issue. The phase 2 study involved 125 patients aged 33 ...
Read More
You have just read an article categorized health
titled Non-Hodgkin Lymphoma Gets Easier to Treat With a New Drug.
Written by:
editor -
Thursday, January 23, 2014
There are currently no comments for "Non-Hodgkin Lymphoma Gets Easier to Treat With a New Drug"
Post a Comment